Shows
The BioHub: The Top Voices in BiotechEpisode 56– Alec Ford & Stacy Solorio - CEO and Chief People Officer at KariusSo welcome back to another episode of the Bio Hub, we were delighted to welcome Alec Ford (CEO of Karius) and Stacy Solorio (Chief people Officer at Karius). Alec is a veteran of the genomics and biotech industries with over 30 years of leadership experience. Alec is leading the charge in transforming infectious disease diagnostics through Karius’s groundbreaking liquid biopsy test, which uses microbial cell-free DNA and AI to detect over 1,000 pathogens from a single blood draw. Before joining Karius, Alec served as COO at Myriad Genetics, where he scaled diagnostics across oncology, women’s health, and prenatal care, and...2025-07-1836 min
Capitol Weekly PodcastClaire Conlon: Around the world and back againClaire Conlon has a long history in the capitol community. She got her start as a legislative aide in 2011, and has held a wide variety of roles since, including Press Secretary for Senate leader Kevin de León and Chief of Staff to Asm. Cottie Petrie-Norris. While building that impressive resume, she did something unusual: she left. In 2017 Conlon left the capitol, the state, and eventually the country, traveling the world for a full year - job title "Vagabond" on her Linkedin. Returning to the state in 2018, she picked up where she had left off. In 2023, she left the c...2025-03-1731 min
PACEing Your FutureInnovation At The Biocom Institute with Vicki BrannockVicki Brannock leverages over 20 years of experience in higher education program development, workforce development, and digital marketing strategy to grow the talent pool in California's life science industry. As a key figure at Biocom Institute, she ensures first-to-market access to top talent through signature programs and strategic partnerships in education and industry. Previously, she held senior roles at Brandman University and the San Diego Workforce Partnership, building deep relationships with workforce development boards and educational institutions across California. Vicki also writes and consults on the future of work, organizational structure, change management, and program design....2025-03-0743 min
Silicon Valley ImpactS2 E7 - Jessica Karr of Coyote Ventures and Genevieve LeMarchal of Suncoast VenturesOn this week's episode of Silicon Valley Impact we speak with Jessica Karr, Founder & Managing Director of Coyote Ventures; and Genevieve LeMarchal, Managing Partner of Suncoast Ventures.
Jessica is passionate about innovation that drives positive change in human health, equality, and our relationship to the earth. She worked for 6+ years designing and launching the Impossible burger as the 12th employee. Jessica has advised and consulted over a dozen companies internationally on product strategies. Jessica is an angel investor, LP, and formerly worked as Principal at a celebrity’s venture fund. She launched Coyote Ventures is 2021 to...2025-02-251h 00
San Diego Daily News and Info TrackerSan Diego's Transformation: The Rise of Sustainable, Connected, and Community-Driven DevelopmentsSan Diego is poised for significant transformation in the coming years, driven by several key trends and developments in its commercial construction, economic growth, and community initiatives.In the realm of commercial construction, San Diego is expected to see a surge in mixed-use developments by 2025. These projects will combine residential, retail, and office spaces, aligning with mixed-use zoning regulations that promote urban density and efficient land use. This trend is anticipated to reduce commute times, improve walkability, and enhance social interaction, often integrating seamlessly with public transportation systems. Urban redevelopment and revitalization projects are also on the rise...2025-02-1903 min
Tacos and Tech PodcastThis Week in San Diego Tech - January 30, 2025Listen & subscribe on Apple, Spotify, YouTube, and other platforms. Welcome everyone to the weekly San Diego Tech News! I’m Neal Bloom from Fresh Brewed Tech, the Tacos and Tech Podcast, and Interlock Capital. My co-hosts in this episode is Fred Grier, journalist and author of The Business of San Diego substack. He covers the ins-and-outs of the startup world including breaking news, IPOs, fundraising rounds, and M&A through his newsletter. AND Jonah Peake Jonah Peake, runs The Social Coyote & the Career Coyote newsletters , promoting events and jobs in the San...2025-01-3044 min
The Derm Vet Podcast237. What is MicroSilver and how can it help your derm patients?I welcome back Dr. Galia Scheinberg on the podcast this week! Dr. Scheinberg has a lot of experience using the Vetbiotek products which contains MicroSilver. How is this ingredient compared to other silver containing products?Microsilver has a larger surface area, allowing for more positive ions to be released and for longer periods of time. Also, microsilver clings to the fur and skin, for prolonged contact without any systemic absorption.Learn all about the Vetbiotek line which contains MicroSilver and Ceramide III. You can check out all of the options at https://nextmune.shop/.2024-09-1232 min
Progress, Potential, and Possibilities Podcast / ShowDr. Benjamin Oakes, Ph.D. - CEO, Scribe Therapeutics - Engineering The Future Of Genetic MedicineSend us a textDr. Benjamin L. Oakes, Ph.D., is Co-Founder, President, and Chief Executive Officer at Scribe Therapeutics ( https://www.scribetx.com/ ), a molecular engineering company focused on creating best-in-class CRISPR-based therapies that permanently treat the underlying cause of disease. Previously, as an Innovative Genomics Institute Entrepreneurial Fellow, Dr. Oakes focused on the holistic engineering of genome editing technologies to build novel genome editing molecules.Dr. Oakes has contributed to over 35 publications and patent applications across synthetic biology, molecular engineering, CRISPR, and zinc finger-based genetic modification. Dr. Oakes has been named t...2024-09-1146 min
The MTPConnect PodcastBiocom California's Mission to Connect Down UnderBiocom California is the US state’s advocate for the life sciences industry with a network of over 1700 members. With offices located in San Diego, Los Angeles, San Francisco Bay Area, Sacramento, Washington, D.C, and Tokyo the group is focused on building international collaborations and networks to bring new medicines to patients.MTPConnect recently signed an MoU with Biocom California during a visit to San Diego for the 2024 BIO Convention to strengthen ties between the US and Australian life sciences sector. In this episode, MTPConnect CEO Stuart Dignam joins host Caroline Duell to chat wit...2024-09-0640 min
Vital Health PodcastJoe Panetta – Policy Impacts on California BiopharmaWith the continuing pressure placed upon the US biopharma sector from Washington DC, how is the California biopharma ecosystem, arguably the leading hub for innovative biotech worldwide, responding? In this Vital Health Podcast, we speak with Joseph Panetta to discuss this issue. Joe is the President & CEO of Biocom California, an organization representing over 1,800 members working in California's life sciences sector to break down barriers to doing business and advocate for innovation. As the head of Biocom California since 1999, Joe is regarded as a thought leader in biotech and life sciences globally.See omnystudio.com/listener for pri...2024-08-0127 min
Beginner's MindEP 134 - The Secret Sauce of California’s Biotech Success Revealed by Joe Panetta🚀 Discover the Secret Sauce Behind California’s Biotech Success with Joe Panetta Unlock the keys to California’s biotech boom as we delve into the insights of Joe Panetta, President and CEO of Biocom California. In this episode, we explore the unique factors that have made California a global leader in biotech innovation. Whether you’re a CEO, investor, or biotech enthusiast, this episode offers invaluable lessons and strategies. 🎙️ What's in the Episode:1️⃣ Convergence of Science and AI: Learn how the integration of advanced technologies is revolutionizing biotech.2️⃣ Risk-Taking Cu...2024-06-221h 03
Biohacking Beauty: The Anti-Aging Skincare PodcastDr. Stephanie Venn Watson: The discovery of C:15:0, Aging, Wellness, and Skin HealthDo you think dolphins have good skin? It turns out that dolphins have a recently discovered fatty acid, C-15, that is linked to anti-aging benefits and holistic wellness. C-15 is the first newly discovered essential fatty acid identified in nearly a century. Pentadecanoic acid, also known as C-15, is an essential fatty acid that defies the norms of cellular fortification.In this episode of the Biohacking Beauty podcast, Amitay, CEO of Young Goose, sits down with Dr. Stephanie Venn Watson of Seraphina Therapeutics to discuss C-15 and its potential benefits of lowering cholesterol, reducing inflammation, decreasing tissue...2024-04-2458 min
Materie PodcastMikroorganismen im Einsatz für Lebensmittelsicherheit - Martin Reich
Folge 42: Mit „Revolution aus dem Mikrokosmos. Nachhaltige Ernährung durch Fermentation“ hat der Biologe Martin Reich im März sein erstes Buch vorgelegt. Die dichte Lektüre erläutert anschaulich, wie Fermentation in größerem Maßstab genützt werden kann, um nachhaltige Nahrungsmittelproduktion und Ernährungssicherheit zu gewährleisten.
Martin Reich ist Gründer des Vereins Öko-Progressives Netzwerk und wissenschtlicher Mitarbeiter in der Kommunikationsagentur Biocom.2024-04-1549 min
The Founders SandboxResilience: Journalist to Venture CapitalistOn this episode of The Founder's Sandbox, Brenda speaks with Genevieve LeMarchal about Resilience: Journalist to Venture Capitalist. They speak about Genevieve's "Phoenix Manifesto", and what journalism and venture capitalism have in common. Genevieve LeMarchal is the Managing Partner of Suncoast Ventures, an early stage venture capital fund specializing in healthcare impact and equity funding opportunities in medical AI, digital health, health tech, medtech and select therapeutics. She launched and ran Expert Dojo’s healthcare program and ran 3 full cohorts of health tech and medtech companies, becoming one of the most prolific early stage vc investors in Sou...2024-04-0441 min
Szon.huKedvenc verseivel lép a közönség elé
A szakmák nagy részében a hozzáértés mellett a megfelelő kommunikáció is elengedhetetlen – jól tudja ezt Tarczy Gyula rendezvénymoderátor, kétszeres Kazinczy-érmes, Szavak embere-díjas konferanszié, a Nyíregyházi Televízió és a Nyíregyházi Napló főszerkesztője, a Biocom kommunikációs vezetője, akivel a január 23-ai önálló estje apropóján beszélgettünk: kíváncsiak voltunk arra, szerinte mitől válhat valaki jó műsorvezetővé, de természetesen arról is mesélt, milyen szerepet játszanak az életében a versek.2024-01-2026 min
Lab Rats to UnicornsJulie Gilmore _ e.046On this episode of "Lab Rats to Unicorns," we sit down with Julie Gilmore, Ph.D., Lilly’s vanguard in bridging the worlds of big pharma, startups, and academia. With over two decades at Lilly, Julie unpacks the role big pharma plays in scientific innovation and the multifaceted career paths and opportunities within it. We'll delve into her experiences in portfolio management, explore the nuances of life science communications, and dissect Lilly’s synergistic relationship with burgeoning startups and universities. Julie also shares her personal narrative of growth and leadership, her mentoring philosophies, and her acumen in spotting potential in t...2023-11-2250 min
Tacos and Tech PodcastThis Week in San Diego Tech News - October 23, 2023Happy San Diego Startup Week! #SDSW2023 Welcome everyone to the weekly San Diego Tech News by Neal Bloom and Fred Grier. I’m Neal Bloom from Fresh Brewed Tech, the Tacos and Tech Podcast, and Interlock Capital and I’m Fred Grier, journalist and author of SD Founders substack. I wrote about the tech industry for the San Diego Business Journal for two years. I covered the ins-and-outs of the startup world for much of that time, breaking news on IPOs, fundraising rounds, and M&A. Oct 23 - News Beyon...2023-10-2327 min
Molecule to Market: Inside the outsourcing spaceFrom CDMO exit to CDMO+In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Tim Scott, President and CEO, AustinPx.
Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Tim, covering:
The founding story of Pharmatek, and how client centricity and ‘training the hell out of the team’ contributed to the growth
How the niche of being a spray drying expert led to a sale of Pharmatek to Catalent... and why he didn’t last very long post-acquisition
The disruptive technology and team that got Tim so excite...2023-08-0446 min
LifeLines by Biocom CaliforniaEpisode 9: Engineering Antibodies Through AI and Machine Learning to Accelerate the Design of More Effective Treatments for PatientsDecades ago, the terms “artificial intelligence” and “machine learning” were associated with rogue robots and nefarious computers in sci-fi books and movies. Today, these technologies are a part of our everyday lives and as innocuous as predictive text appearing in a messaging app, a robot on wheels delivering food to your table at a restaurant, or a student using Chat GPT for writing prompts. But what applications does AI, big data, and machine learning have in life science?
On this week’s episode of LifeLines, our final episode of Season 1, we chat with Peyton Greenside, Ph.D., co-founder a...2023-08-0223 min
Vital Health PodcastBiocom California Grapples with Regulatory Assaults on all FrontsWith the Inflation Reduction Act now law, there are mounting concerns that its drug pricing revisions will have a huge negative impact on the California Biotech ecosystem, arguably, the globe’s leading hub for innovative biotech. Joseph Panetta is President & CEO of Biocom, the San Diego, California organization leading 1200 companies, service sector firms, universities and research institutes working in the biotechnology sector. Joe’s been the head of Biocom since 1999 and is universally regarded as one of the world’s biotech thought leaders. In this Vital Health Podcast, Joe Panetta and Duane Schulthess discuss the IRA, the Smart...2023-07-2042 minLifeLines by Biocom CaliforniaEpisode 8: Building a Collaborative Incubator Community for Orange County Biotech StartupsMention Orange County to the average person and images of Disneyland, Laguna Beach and high-end shopping malls may come to mind. Life science industry insiders know that beyond the county’s famous landmarks is a nascent biotechnology hub—more than 63,000 people there were employed by the sector last year, and the number of startups establishing roots in Orange County is growing. In 2020, biotech startups gained a new place to set up shop when University Lab Partners, the first wet lab incubator for biotech and medtech companies in the region, opened near the University of California, Irvine campus. Karin Koch, its...2023-07-1925 minLifeLines by Biocom CaliforniaEpisode 7: Mapping the Growth of the Bay Area's Life Science Industry and Providing Startups with the Tools to Scale and SeedThe San Francisco Bay Area is known as the “birthplace of biotech” and a center of the tech world, but did you know the local biomedical industry—companies developing new drugs and foods, medical devices and equipment, digital healthcare, and more—number in the thousands in the region? And that where a life science company first sets up shop in the Bay Area can indicate where it may move to in the future?
Gregory Theyel, Ph.D., a biomedical engineer and professor at California State University East Bay, discovered this ten years ago when he first sought out start...2023-07-0526 minLifeLines by Biocom CaliforniaEpisode 6: Landing Multi-Million Dollar Partnerships for Next-Gen Gene Therapies While Addressing Gender Parity in Life Science LeadershipHow does a biotech startup manage to forge $125 million in partnerships with AbbVie and Eli Lilly in just under two years post-inception? Our next guest, Peter Anastasiou, CEO of Capsida Biotherapeutics since 2022, attributes much of the company's rise to addressing unmet patient needs. First invented by Viviana Gradinaru, director of the Center for Molecular and Cellular Neuroscience at the Chen Institute for Neuroscience at the California Institute of Technology, Capsida’s next-generation gene therapy platform engineers the capsids in adeno-associated viruses, or AAVs. The company uses this technology to develop treatments that are being researched for central nervous system and...2023-06-2118 minLifeLines by Biocom CaliforniaEpisode 5: Creating a Bridge from Higher Education to Real-Life Science Application as a First-Ever Female DeanKit Pogliano says her colleagues from graduate school would have voted her the least likely person from class to go into university administration, let alone become a dean of an entire school. But after building a 20-year career as a professor, researcher, and leader at University of California, San Diego, she became the first female Dean of the School of Biological Sciences—which U.S. News & World Report ranks as No. 7 in the world for its biology and biochemistry programs—in 2018.
Kit’s research focuses on how bacteria cells are organized, grow, and interact with antibiotics and ways to...2023-06-0713 minLifeLines by Biocom CaliforniaEpisode 4: Making the Leap from Academia to Blazing His Own Trail in Biotech in Pursuit of Novel Cancer TreatmentsWhat do Magic Johnson, the McGovern Medical School at UTHealth Houston, and a molecule have in common? They each played an unexpected role in changing the course of our next guest, Stanley Lewis, CEO and founder of San Diego-based A28 Therapeutics, on his path toward finding a novel treatment for cancer and advocating for patient diversity in clinical trials.
On this episode of LifeLines, Stanley speaks about his journey from academia to blazing his own trail in biotech and founding his own company. As a physician, Stanley specialized in treating HIV patients and helped lead the development...2023-05-2416 minLifeLines by Biocom CaliforniaEpisode 3: Daré Bioscience is Advocating For Equity in Women’s Health and Building a Pipeline of Differentiated Treatment OptionsWomen make up half of the globe’s population, but the dollars devoted to finding treatments for women’s unique health issues—beyond conditions such as breast cancer—are significantly underfunded. Only 1 percent of research dollars are invested in women's health concerns, and women's health represents only 2 percent of the development pipeline of preclinical products for non-cancer related conditions, according to a 2022 McKinsey & Company report. Sabrina Martucci Johnson, president and CEO of Daré Bioscience, says this is not congruent, at all, with the need and demand for such products and the fact that women account for 80 percent of consumer purchase...2023-05-1029 minLifeLines by Biocom CaliforniaEpisode 2: Democratizing Sequencing to Address Genomic Data Inequality and Improve the Future of MedicineElement Biosciences is on a mission to democratize next-generation sequencing by helping scientists overcome a major lack of diversity in genomic studies. A recent article in Nature Medicine cited that as of June 2021, 86 percent of genomics studies have been conducted in individuals of European decent, leaving researchers without adequate data representing our global population. The promise of genomic research equates to improving our understanding of disease etiology, early detection and diagnosis, drug design and clinical care. Without representation of all populations, we’re missing a big piece of the puzzle that allows the advancement of health for humanity. By re...2023-04-2626 min
Soul of Business with Blaine BartlettGenevieve LeMarchal, Managing Partner of Suncoast VenturesMoney Has A Heart And A Soul! Meet my guest Genevieve LeMarchal, Managing Partner of Suncoast Ventures. She launched and ran Expert Dojo’s healthcare program and ran 3 full cohorts of health tech and MedTech companies, becoming one of the most prolific early stage VC investors in Southern California (Crunchbase, 2022) and winner of the 2022 Biocom Lifescience Catalyst Award. She previously served as Partner at a science focused advisory and fund in formation, was a General Partner at Oregon-based FoundersPad VC Fund II and she is co-founder of the XXcelerate Fund. She is the host of the AdVentureous Podcast. Genevieve wri...2023-04-1733 minLifeLines by Biocom CaliforniaEpisode 1: Revolutionizing How Clinicians Detect Infections in Immunocompromised PatientsKarius’ story is all about equipping doctors with the right information, for the right patient, at the right time. For most immunocompromised patients, it’s a matter (quite literally) of life or death.
When Alec Ford’s daughter was just a toddler, she suffered with asthma and caught a viral infection that led to secondary bacterial infections and was hospitalized multiple times. Alec says he watched doctors try to help his daughter, but the tools they had to figure out exactly how to provide the best anti-infective care for her were all a failure. “They couldn't find the cause...2023-04-1236 minLifeLines by Biocom CaliforniaComing Soon: LifeLines Season 1Biocom California’s new podcast, LifeLines, brings you direct access to leaders in the life science industry for candid one-on-one conversations about the journeys they’ve taken, both professionally and personally, toward bettering human and environmental health. Biocom California is a member and advocacy organization that accelerates life science success in California and beyond. With over 1,700 companies in our network, we hear inspiring stories every day about founders who beat the odds and the relentless pursuit to improving the human condition. We are so proud to share these stories of success, determination, and innovation with the world.
In t...2023-04-0502 min
Biotech 2050 PodcastJPM23 Special: Rare diseases, Eslie Dennis, Kyowa Kirin, Arthur Suckow, DTx, & James Mackay, AristeaSynopsis:
This special episode features a panel discussion with three biotech leaders about drug development for rare diseases. James Mackay, Ph.D., is the Founder, President and CEO of Aristea Therapeutics, an immunology-focused clinical stage biotech that is focused on inflammatory diseases. Arthur T. Suckow, Ph.D., is the Co-Founder and CEO of DTx Pharma, which is focused on developing novel technology for delivery of RNA medicines. Eslie Dennis is the SVP and CMO of Kyowa Kirin North America, a Japan-based global specialty pharmaceutical company. Our guests discuss the patient journey for those living with rare diseases, the importance of...2023-01-1136 min
Health Professional Radio - PodcastDTx Pharma - FALCON™ (Fatty Acid Ligand Conjugated OligoNucleotide)Dr. Arthur Suckow, CEO of DTx Pharma, a San Diego-based biotechnology company developing novel RNA-based therapeutics to treat the genetic drivers of rare diseases, discusses the current challenges with RNA therapeutics and the development of a platform called FALCON™ (Fatty Acid Ligand Conjugated OligoNucleotide).
#DTxPharma
Dr. Suckow founded DTx Pharma in 2017. An innovative leader in drug discovery, he previously worked on the ophthalmology, diabetes, and NASH programs at Regulus Therapeutics, at the MedImmune arm of AstraZeneca, and in the Diabetes Drug Discovery program at Johnson & Johnson. Dr. Suckow received his BS from the University of De...2022-10-0408 min
The Health Design PodcastGay Grossman, patient advocate.Gay has been active in the Rare Disease community for over two decades and continues her efforts to build and support patient and family advocacy.
Co-founded ADCY5.org, the foundation for ADCY5-related dyskinesia. ADCY5.org supports world-renowned researchers who study the gene and its variant. She continues to build a community of hundreds with this disease, when they started with only 1.
She is an advocate of genetic testing, shared data, and patients owning their data. Her focus remains to help all Rare Disease patients find testing and teach them how to maintain health records.
Gay successfully advocates for access...2022-08-2237 min
TechNation Radio PodcastEpisode 22-30 Biotech meets in person !!On this week’s Tech Nation, Moira speaks with the biotech companies at the BIO International Convention in San Diego. They meet in person for the first time in 3 years, where Dr. Gunn was able to speak with Paul Hastings, the Chair of BIO and the President & CEO of Nkarta, about the state of BIO and Nkarta’s work on delivering Natural Killer cells for cancer. Joe Panetta, President & CEO of Biocom California, brings insights into California as a whole and its relation globally, as well as the price of drugs. Dr. Richard Austin, founder and CEO of Reglagene talk...2022-07-2159 min
Vital Health PodcastJoe Panetta Steers Biocom California’s Members Through Increasingly Stormy Seas It seems every week we hear of another new proposal out of Washington DC to ‘fix’ drug pricing, and many of the companies that would be impacted by these proposals are in California, arguably, the globe’s leading biotech hub, and where the sector was born. Joe Panetta is President & CEO of Biocom California, the association representing the life science industry in California. With offices in San Diego, Los Angeles, Sacramento, and the Bay Area, Biocom California advocates for more than 1,600 companies, service sector firms, universities, and research institutes working across the state in the biotechnology sector. Joe’s been the...2022-07-0128 min
BIOS43. Future of Genetic Medicine w/ Scribe Therapeutics Founders - Ben Oakes & Dave SavageBen Oakes is Co-founder, President, & CEO @ Scribe Therapeutics. He has contributed to over 25 publications and patent applications across synthetic biology, molecular engineering, CRISPR, and zinc finger-based genetic modification. A previous Innovative Genomics Institute Entrepreneurial Fellow, Ben has been named to the San Francisco Business Times 40 Under 40, Endpoints 20 Under 40 in biopharma, Business Insider 30 Under 40 transforming healthcare, and the Biocom Life Sciences Catalyst Awards. He received a PhD in Molecular and Cellular Biology from the University of California, Berkeley, where he worked in the Doudna Lab and Savage Lab developing CRISPR-Cas9 molecules with enhanced characteristics.Dave Savage is Co-founder...2022-04-1143 min
Biotech 2050 Podcast90. From pharma to founding a biotech, James Mackay, Founder, President & CEO, Aristea TherapeuticsJames Mackay, PhD, Founder, President and Chief Executive Officer, has over 25 years of development and commercialization expertise in the pharmaceutical industry, including 6 drug product approvals across multiple therapeutic areas. Prior to founding Aristea, he was President and Chief Executive Officer of Ardea Biosciences, Inc., following the company’s acquisition by AstraZeneca in 2012. James was instrumental to setting up an innovative model for Ardea Biosciences that retained the biotech’s independence and accountability for the development of the gout franchise while also developing a synergistic and collaborative relationship with the parent company, AstraZeneca. Prior to Ardea, James held senior executive positions at A...2022-02-1624 min
Tacos and Tech PodcastSan Diego Tech News Weekly – October 1, 2021This Week in SD Tech: San Diego maintains in the top 3 biotech cities in the country, with 1 in 30 jobs in the life sciences industry locally, new report by Biocom UCSD is making strides in building a battery with 10 times the energy density of current batteries Bayer buys out Vividion Therapeutics for $2B Magic Johnson joins forces with Qualcomm to bring smart city technology to inner cities to break the digital divide Results from a recent SD EDC business health survey shows companies are struggling to keep up with the resurgent growth 2021-10-0222 min
The Skeptics Guide to Emergency MedicineSGEM#332: Think Outside the Cardiac BoxDate: May 20th, 2021
Guest Skeptic: Dr. Robert Edmonds is an emergency medicine physician in the Air Force in Dayton, Ohio, and a University of Missouri-Kansas City residency alumni from 2016.
Reference: Jhunjhunwala et al. Reassessing the cardiac box: A comprehensive evaluation of the relationship between thoracic gunshot wounds and cardiac injury. Journal of Trauma and Acute Care Surgery. September 2017
DISCLAIMER: THE VIEWS AND OPINIONS OF THIS PODCAST DO NOT REPRESENT THE UNITED STATES GOVERNMENT OR THE US AIR FORCE.
This SGEM episode was recored live for the Truman Medical Centers Multidisciplinary Trauma Conference. We did the session over zoom as an SGE...2021-05-2925 min
Anti-Aging HacksHow Mitochondrial Peptides Can Help You Beat Disease & Live Longer and Healthier: Steven EngleOn this episode of Anti-Aging Hacks, Steve Engle and Faraz Khan discuss how mitochondrial peptides can help you beat disease and live longer. Here are some points we discuss: 1. Why your mitochondria is so important for your health? 2. How mitochondrial peptides can help beat major diseases and give you a longer life? 3. How Cohbar's stacked team of experts is helping bring these to market. You can find the show notes for this episode at https://www.antiaginghacks.net/cohbar Steve Engle joined CohBar as Chief Executive Officer...2021-04-241h 10
Health Professional Radio - PodcastPersephone Biosciences - Gut Microbiome and COVID-19 Vaccine StudyDr. Stephanie Culler, Ph.D., co-founder and CEO of Persephone Biosciences discusses their VOICES (Vaccine Observation to Include all Communities for Equitable Science) study, a non-interventional, single-site study enrolling people in the U.S. being administered a COVID-19 vaccine. The goal is to identify and determine specific gut microbiota and the metabolic processes that are involved in an optimal immune response.
Dr. Culler is a graduate of the prestigious Y Combinator accelerator, a recipient of the BIOCOM catalyst award and has spoken at TEDx San Diego. Prior to establishing Persephone Biosciences, she was a senior scientist at...2021-04-1210 min
ÄrzteTagWie Arzneimittel mithilfe von Moosen hergestellt werden könnenDer Pflanzenbiotechnologen Professor Ralf Reski im Gespräch
Was in tierischen Zellen nicht gelungen ist, klappt in Mooszellen: die biotechnologische Herstellung von Faktor H. Jetzt wird das Verfahren optimiert und präklinisch getestet. Eine Phase-1-Studie erfolgreich abgeschlossen hat bereits das Enzym moss-aGal, eine α-Galaktosidase, die mittels Mooszellen produziert wird.
Damit die Mooszellen – also pflanzliche Zellen – humane Proteine synthetisieren, müssen sie verändert werden: Bestimmte Gene werden ausgeschaltet, andere hinzugefügt. Damit werden die Zuckerstrukturen der Glykoproteine des Mooses dem des Menschen angepasst.
In Mooszellen hergestellte Proteine können sogar besser wirken als ihr Pendant aus...2021-03-2316 min
Health Professional Radio - PodcastNASA Research on the Effects of Space Travel on MitochondriaSteven Engle, CEO of CohBar, Inc, a clinical stage biotechnology company discusses his article in "Grit Daily" (Jan 8, 2021) on NASA's breakthrough study published in "Cell" (Nov 25, 2020) on the effects of space travel on mitochondria.
Mr. Engle joined CohBar as Chief Executive Officer and Director in 2019. From 2011 to 2019, he served as the Chief Executive Officer of Averigon, an advisory firm to the life science industry. From 2007 to 2011, Mr. Engle was Chairman, Chief Executive Officer and President of XOMA Corporation (NASDAQ: XOMA), a publicly traded biotechnology company developing antibody therapeutics for multiple diseases. From 1993 to 2006, he held several executive management roles including...2021-02-0709 min
Risky BenefitsFighting Cancer with Cancer Guardian - Episode #24Nick Bellanca and Darren Rowe from Cancer Guardian are on mic to explain genomics and how genetic testing and a dedicated support team make a big impact in early cancer prevention, detection, and treatment. Listen, and learn more about how Cancer Guardian works and the current state of cancer support and treatment in a COVID-19 environment.MORE ABOUT OUR GUESTS:Darren RoweChief Innovation Officerwamberggenomic.comA co-founder and former CEO of the UK’s largest independent cancer navigation company, Darren is WGA’s Ch...2020-12-0145 min
Conversations in HealthcareCollaborating with officials to continue developmentsIn this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Joe Panetta, President and CEO of BIOCOM. Joe talks around how BIOCOM has worked closely with government officials to ensure the life science community can continue to function throughout the COVID-19 pandemic, and how they’ve worked with these officials to develop guidance for this community on how they can safely return to work. Joe discusses how COVID-19 has affected funding for biotech companies, the ability to build international relationships with global companies and how new digital practices su...2020-11-1839 min
Ideas, energized.Raising the Next Generation of STEM Leaders feat. City of STEM and Biocom InstituteJoin our guest host Ben Dickow (Executive Director of the Columbia Memorial Space Center and City of STEM Festival director) in conversation with Karmin Noar (Executive Director of Biocom Institute) and Rohit Shukla (Founder and CEO of Larta Institute) as they discuss how the Greater LA Region has contributed to the empowerment of STEM education, what diversity means to them, and how we can raise the next generation of STEM leaders as part of the legacy of Los Angeles.
***
City of STEM officially kicks off with a virtual event streaming LIVE on Youtube on Saturday, Oct...2020-09-291h 05
Community Spotlight ShowInstitute Develops Talent Pipeline to Grow Life Sciences Ecosystem in RegionKarmin Noar, Executive Director of the Biocom Institute, chats about the Institute's mission, high school internship program and Military Fellowship.2020-02-2429 min
The Leadership Journey3 Strategies to Supercharge your Executive Career76% of Senior Executives report they’re miserable in their roles...here’s how to change that.
For the first time in 50 years, job candidates control the market! Why are many executives feeling dissatisfied in their current role? Much of it is because senior leaders and executives become so busy setting and executing strategy with their teams, they don’t take the time to design their own career strategy. What are you currently doing to proactively manage your career?
In this podcast Kelli McCauley, President of McCauley & Company talks with Mark James, author of Keys to the CSuite, Executive Recruiter, Founder and Pre...2019-06-1817 min
Rise Up Network's PodcastEpisode 130: Featuring (Part I)Tim Lafleur and Tom Garcia, and (Part II) Liisa BozinovicHost: James Carmody
Part I:
1. Tim Lafleur - One of two Honorary Chairs of the Commissioning Committee
2. Tom Garcia - Chairman of the Commissioning Committee
MONSOORCOMMISSIONING.ORG
Part II:
Liisa Bozinovic - Executive Director of Biocom Institute
BIOCOMINSTITUTE.COM
@biocominstitute
2019-04-1240 min
No Such Thing: Education in the Digital AgeCompetency XDel Lago Academy is one use case that shows the potential of alternative credentialing (or digital badges) for reforming assessment in the digital age. If you're a K12 professional, a funder, or a education technologist that's been following the conversation on Badges for Learning, you don't want to miss this conversation. Alec Barron is the lead behind Competency X, a project that's already engaged teachers, local industry, and higher ed in a serious conversation about how competency-based practices, along with strong software platforms, can change the efficiency and effectiveness of school-supported pathways for youth to meaningful, prosperous futures in...2018-10-051h 13
Science Changing LifeEpisode 3 - Matt Tremblay: Technology Transfer - From Bench to BedsideMatt is the Vice President of Business Development at TSRI, as well as Chief Operating Officer at Calibr. Listen as we talk about what constitutes commercially valuable research, why TSRI is #1 for science innovation and how to design a home jungle gym.
Show notes:
Matt’s recent Biocom Catalyst Award
http://www.scripps.edu/newsandviews/i_20171002/20171002tremblay_biocom.html?utm_source=newsviews&utm_medium=email&utm_campaign=internal20171002
Calibr Bio
http://www.calibr.org/about/institute-leadership/
TSRI-Calibr partnership
https://www.eurekalert.org/pub_releases/2016-10/sri-tac102016.php2017-12-1927 min
Business Black Belt®Deal Terms for Angel Investors - Bob KramarzAngel Investor, Rob Kramatz, Shares His Thinking on Investing in Companies, and Some New Ideas for Structuring the Deal Terms I‘m talking with Rob Kramarz, a serial entrepreneur and investor with interests in life sciences and technology. He’s been active in San Diego Venture Group, OCTANe (an accelerator in Orange County), Tech Coast Angels, Connect and the Biocom Capital Committee . With a background in technology management, Mr. Kramarz is currently managing director of 22nd Century Ventures, which is raising a fund and is a partner with Vantera Partners, which advises mid-market companies on financing, mergers and exits. Mr. Kram...2014-12-0700 min